Receptor-based pharmacophore modeling, molecular docking, synthesis and biological evaluation of novel VEGFR-2, FGFR-1, and BRAF multi-kinase inhibitors
Article in BMC Chemistry (February 2024)
The most recent citing publications are shown below. View all 25 publications that cite this research output on Dimensions.
Therapeutic targeting of hepatocellular carcinoma cells with antrocinol, a novel, dual-specificity, small-molecule inhibitor of the KRAS and ERK oncogenic signaling pathways
Article in Chemico-Biological Interactions (December 2022)
Regorafenib Reverses Temozolomide-Induced CXCL12/CXCR4 Signaling and Triggers Apoptosis Mechanism in Glioblastoma
Article in Neurotherapeutics (March 2022)